BriaCell $BCTX will present new preclinical data on its Bria-OTS+ cancer vaccine platform at the SITC 40th Anniversary Annual Meeting (Nov 7-9). Investors should watch for insights on how Bria-OTS+ Overcomes Immune Resistance. Full PR here: https://globenewswire.com/news-release/2025/10/03/3160903/0/en/BriaCell-to-Present-Bria-OTS-Preclinical-Data-at-SITC-2025-Annual-Meeting.html
(0)
(0)